JYHB1900542 | 盐酸安非他酮缓释片(I) | bupropion hydrochloride | Tablet, extended release | Chemical Drugs(5.1) | Supplementary Application | 2019-05-20 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Bausch Health Companies Inc;Glaxosmithkline Gmbh & Co KG | Certificate Issued | 2020-03-06 | view |
JYHB1900543 | 盐酸安非他酮缓释片(I) | bupropion hydrochloride | Tablet, extended release | Chemical Drugs(5.1) | Supplementary Application | 2019-05-20 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Bausch Health Companies Inc;Glaxosmithkline Gmbh & Co KG | Certificate Issued | 2020-03-06 | view |
CYHS1800392 | 盐酸安非他酮缓释片(I) | bupropion hydrochloride | Tablet, extended release | Chemical Drugs(3) | Generic Drug | 2018-11-02 | 石药集团欧意药业有限公司 | CSPC OUYI Pharmaceutical Co Ltd;Shanghai Anbison Lab Co Ltd | In Review | 2018-11-01 | view |
CYHS1800393 | 盐酸安非他酮缓释片(I) | bupropion hydrochloride | Tablet, extended release | Chemical Drugs(3) | Generic Drug | 2018-11-02 | 石药集团欧意药业有限公司 | CSPC OUYI Pharmaceutical Co Ltd;Shanghai Anbison Lab Co Ltd | In Review | 2018-11-01 | view |
JXHS1800021 | 盐酸安非他酮缓释片(I) | bupropion hydrochloride | Tablet, extended release | Chemical Drugs(5.1) | Import Drug Application | 2018-05-09 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Bausch Health Companies Inc;Glaxosmithkline Gmbh & Co KG | Certificate Issued | 2020-03-06 | view |
JXHS1800022 | 盐酸安非他酮缓释片(I) | bupropion hydrochloride | Tablet, extended release | Chemical Drugs(5.1) | Import Drug Application | 2018-05-09 | 葛兰素史克(中国)投资有限公司 | GlaxoSmithKline (China) Investment Co Ltd;Bausch Health Companies Inc;Glaxosmithkline Gmbh & Co KG | Certificate Issued | 2020-03-06 | view |